31/10/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
03/08/23 GSK Nigeria calls an end to its business, to return cash RE
03/08/23 Glaxo Smithkline Consumer Nigeria To Cease Operations RE
03/08/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
28/04/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
28/01/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
28/01/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
28/10/22 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
29/07/22 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
28/04/22 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
31/01/22 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2021 CI
25/10/21 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
29/07/21 Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Manager TitleAgeSince
Compliance Officer - -
Chief Tech/Sci/R&D Officer - 01/08/2011
General Counsel - 01/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 12.81M
-2.48%+8.34%+53.87%+155.75% 1,070B
-1.76%+6.23%+66.27%+53.44% 611B
-1.05%+7.19%+35.57%+86.77% 445B
-1.18%+4.18%+31.11%+23.88% 329B
+0.70%+2.03%+36.44%+36.80% 290B
-0.06%+1.67%+29.13%+42.78% 287B
+1.34%+1.93%-27.56%-41.34% 213B
+0.44%+4.35%+29.69%+63.10% 195B
+0.01%+1.03%+13.95%+63.93% 157B
Average -0.38%+5.04%+29.83%+53.90% 399.58B
Weighted average by Cap. -1.07%+6.67%+40.38%+78.47%
Logo GlaxoSmithKline Consumer Nigeria Plc
GlaxoSmithkline Consumer Nigeria specializes in manufacturing and marketing pharmaceutical, hygiene and health care products. Net sales break down by activity as follows: - sale of consumer healthcare products (70.7%): nutritional supplements, OTC drugs and oral care products; - sale of drugs (29.3%): antibacterial drugs, prescription drugs and vaccines.
Employees
51
  1. Stock Market
  2. Stocks
  3. GLAXOSMITH Stock